Abstract
The Accreditation Sub-Committee of the EBMT regularly publishes special reports on current practice of haemopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders. Major changes have occurred since the last report in 1998. Haemopoietic stem cell transplantation today includes allogeneic and autologous stem cells derived from bone marrow, peripheral blood and cord blood. With reduced intensity conditioning regimens in allogeneic transplantation, the age limit has increased, permitting the inclusion of older patients. New indications have emerged, such as autoimmune disorders and AL amyloidosis for autologous, and solid tumours for allogeneic transplants. Other indications, such as autologous transplantation for breast cancer have been challenged. An updated report with revised tables and operating definitions is presented here.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Long-term outcome after allogeneic stem cell transplantation in multiple myeloma
Annals of Hematology Open Access 17 April 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schmitz N, Gratwohl A, Goldman JM . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1996 and proposals for an operational classification Bone Marrow Transplant 1996 17: 471 477
Goldman JM, Schmitz N, Niethammer D, Gratwohl A . Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998 Bone Marrow Transplant 1998 21: 1 7
Gratwohl A, Hermans J, Baldomero H et al. Indications for haemopoietic precursor cell transplants in Europe Br J Haematol 1996 92: 35 43
Link H, Schmitz N, Gratwohl A, Goldman JM . Standards for specialist units undertaking blood and marrow stem cell transplants – recommendations from the EBMT Bone Marrow Transplant 1995 16: 733 763
Joint Accreditation Committee EBMT-EuroISHAGE (JACIE) Accreditation Manual
Acknowledgements
The authors are grateful for the advice and helpful comments received from a number of individuals across Europe specialising in the use of haemopoietic stem cell transplantation to treat patients with haematological disorders. Special thanks to T Ruutu, JJ Ortega, G Sanz, F Prosper, E Montserrat, P Corradini and P Dreger.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Urbano-Ispizua, A., Schmitz, N., de Witte, T. et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 29, 639–646 (2002). https://doi.org/10.1038/sj.bmt.1703535
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703535
Keywords
This article is cited by
-
Long-term outcome after allogeneic stem cell transplantation in multiple myeloma
Annals of Hematology (2021)
-
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
Bone Marrow Transplantation (2019)
-
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
Bone Marrow Transplantation (2015)
-
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
Bone Marrow Transplantation (2010)
-
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
Bone Marrow Transplantation (2006)